Jessica Vermeulen | Vice President, Lymphoma & Leukemia Disease Area Stronghold Leader

Jessica is the Disease Area Stronghold Leader for Lymphoma & Leukemia at Johnson & Johnson Innovative Medicine. As part of the global oncology R&D leadership team, she is responsible for the overall strategy to develop a portfolio of transformational therapeutic options for patients with lymphoma and leukemia. In this role, she works with internal and external partners to advance translation of discoveries into treatment options for patients that provide significant improvements in clinical benefit. Prior to this role, Jessica worked as a Clinical Leader in Late Development for Johnson & Johnson Innovative Medicine, leading the development of IMBRUVICA® and DARZALEX® as well as multiple registrations across indications. She was also recognized as an inspirational leader in the PharmaVOICE 100 in 2021. Before joining Johnson & Johnson in 2005, Jessica held several positions at RPR and Sanofi Aventis. Jessica holds an MD and PhD degree from the University of Amsterdam, The Netherlands.